Amp Capital Investors LTD Zai Lab LTD Transaction History

Amp Capital Investors LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $2.11 Million - $4.05 Million	-38,451 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $189,630 - $322,136	-1,806 Reduced 4.49%	38,451 $4.05 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $4.27 Million - $6.14 Million	34,109 Added 554.8%	40,257 $7.13 Million
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $59,346 - $90,103	470 Added 8.28%	6,148 $816,000
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $68,501 - $113,144	836 Added 17.27%	5,678 $762,000
Q3 2020 Nov 12, 2020	BUY	$73.3 - $89.48 $17,005 - $20,759	232 Added 5.03%	4,842 $400,000
Q2 2020 Aug 14, 2020	BUY	$48.82 - $82.53 $225,060 - $380,463	4,610 New	4,610 $381,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.52B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.